Tirzepatide, a dual GLP-1 and GIP receptor agonist, has demonstrated significant weight loss benefits in clinical trials, with participants losing up to 22% of body weight
Product Type & Quantity Type: Oral tablet (prescription medicine) Quantity: 10 tablets per pack Strengths Available: 3mg, 7mg, 14mg Composition Each tablet of Semgo 7mg contains: Active Ingredient: Semaglutide 7mg Indications Semgo 7mg (Semaglutide) is indicated for: Type 2 Diabetes Mellitus (T2DM): Improves glycemic control by stimulating insulin secretion and reducing glucagon levels
Nausea (most common, ~2044% in clinical data), diarrhea, vomiting, and constipation usually mild and fading after 48 weeks
Broadway st Chicago, IL 60613 773-360-8501......#b12 #b12injections #b12chicago olaser #chicagobotox #chicagomedicalspa #vesperchi #vesperaesthetics #vespermedspa #laser #skincare #chicagomedspa #chicagomedicalspa #vesperchi #chicago #chicagobotox #chicagofiller #boystown #lgbtqprovider #nursejuancarlos #lakeviewchicago #northhalstedbusinessalliance #46thwardchicago | JuanCarlos Delgado RN LE